Pfizer UK removes sales incentives for anti-infectives
Pfizer UK has changed how it incentivises its anti-infectives field-force under the drug giant’s commitment to the fight against antimicrobial resistance (AMR).
All sales have been ‘de-linked’ from its anti-infectives (AI) field-force incentives, with the focus now on measuring management-based objectives (MBOs) centering on generating access to medicines and promoting the appropriate use of antibiotics.
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!